Immunomic Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Immunomic Therapeutics, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include UNITE and IMMUNOMIC THERAPEUTICS. The owner is based in Rockville, MD.
15010 Broschart Road
Rockville, MD 20850
Showing of trademarks Trademarks
Trademark Classifications
Immunomic Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Immunomic Therapeutics, Inc. have?
Immunomic Therapeutics, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does Immunomic Therapeutics, Inc. file in?
Immunomic Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Immunomic Therapeutics, Inc.'s most well-known trademarks?
Immunomic Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as UNITE and IMMUNOMIC THERAPEUTICS. These are among 3 currently registered trademarks in the portfolio.
What is Immunomic Therapeutics, Inc.'s trademark registration success rate?
Immunomic Therapeutics, Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.